Table 2 Effectiveness of Vaccination against Symptomatic PCR-confirmed SARS-CoV-2
Crude VE | VE adjusted for | VE adjusted for age, sex, and | |
|---|---|---|---|
(95% CI) | age and sex | history of confirmed COVID-19 | |
(95% CI) | (95% CI) | ||
Gam-COVID-Vac (2-dose Sputnik V) | 43% (34–52) | 49% (40–56) | 56% (48–63) |
Gam-COVID-Vac (1-dose Sputnik Light) | 49% (31–63) | 51% (32–64) | 49% (29–63) |
EpiVacCorona | -105% (-322–1) | -84% (-267–8) | -58% (-225–23) |
CoviVac | 34% (-3–49) | 35% (-3–59) | 40% (3–63) |
Other | -22% (-127–34) | -26% (-125–29) | -1% (-82–44) |
Any vaccine: partial vaccination | 22% (-33–54) | 24% (-33–56) | 25% (-33–58) |